- and holds annual Kids Fun Day
- Conducts awareness sessions and blood sugar tests across schools, companies and government entities
Abu Dhabi, United Arab Emirates, 25 November 2024: Imperial College London Diabetes Centre (ICLDC), part of the M42 group, marked Diabetes Awareness Month with several events throughout November, including participation in the Al Dhafra Hospitals Third Health Forum 2024 and hosting its annual Kids Fun Day.
ICLDC also organised a comprehensive schedule of awareness sessions across numerous schools, companies, and government entities within the Emirate of Abu Dhabi. Activities included blood sugar testing, BMI checks, dietician consultations and other health initiatives.
During the Kids Fun Day, young patients engaged in interactive games and workshops, learning key aspects of diabetes management, including healthy eating habits, exercise routines and the importance of monitoring blood sugar levels.
Diabetes remains a significant health issue in the UAE, with high rates of both type 1 and type 2 diabetes. The International Diabetes Federation predicts that 1.17 million people in the UAE (aged 20-79) could have diabetes by 2030.
Dr. Mai Aljaber, CEO, at Imperial College London Diabetes Centre said, “Public health is our top priority, and we have already reached almost 7,000 individuals across the UAE through our outreach programme this year, with a goal to surpass 8,000 by the year’s end. Since our inception, our public health campaigns have successfully raised diabetes awareness, reaching an impressive audience of more than 180,000 individuals.”
About Imperial College London Diabetes Centre
Imperial College London Diabetes Centre (ICLDC), an M42 company, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training, and public health awareness. In just over a decade, the Centre has gained international renown for its holistic approach to the treatment of diabetes and related complications that enables patients to receive the full spectrum of care they need in one place.
With more than 80 diabetes professionals and endocrinologists under one roof, Imperial College London Diabetes Centre offers best-in-class medical attention from first diagnosis to disease management across 11 specialist practice areas including adult and paediatric endocrinology, treatment of metabolic and electrolyte disorders, pre- and post-bariatric surgery care, heart disease prevention, nutritional advice, diabetes education services, ophthalmology, nephrology, and podiatry.
ICLDC was established in 2006 in Abu Dhabi by Mubadala in partnership with the UK’s Imperial College London to address the growing demand for diabetes care in the UAE. The centre now operates three branches across Abu Dhabi and Al Ain, touching the lives of more than one million people through patient-centric programmes and public health initiatives. In 2007, ICLDC launched Diabetes. Knowledge. Action, now the longest running public health awareness campaign in the country. The initiative promotes an active lifestyle through an ongoing calendar of events for the whole community – Major activations include an annual walkathon that coincides with the World Diabetes Day in November.
ICLDC holds the Joint Commission International (JCI) Clinical Care Program Certification in Outpatient Diabetes Management and JCI Accreditation for Ambulatory Care.
For more information, please visit www.icldc.ae
About M42
M42 is a first-of-its-kind, global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative solutions that are solving the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalized, precise, and preventative health solutions to impactfully disrupt the global health landscape.
M42 has over 20,000 employees and more than 450 facilities in 26 countries. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 combines leading health technologies with state-of-the-art healthcare facilities to deliver world-class health solutions, services and care.
The M42 group includes Diaverum, Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre and Moorfields Eye Hospital Abu Dhabi, among others.